Variants in the L12 linker domain of KRT10 are causal to atypical epidermolytic ichthyosis.

KRT10 epidermolytic ichthyosis keratin 10 linker domain peeling skin

Journal

The Journal of dermatology
ISSN: 1346-8138
Titre abrégé: J Dermatol
Pays: England
ID NLM: 7600545

Informations de publication

Date de publication:
29 Jul 2024
Historique:
revised: 05 07 2024
received: 14 03 2024
accepted: 09 07 2024
medline: 29 7 2024
pubmed: 29 7 2024
entrez: 29 7 2024
Statut: aheadofprint

Résumé

Epidermolytic ichthyosis (EI) is a type of congenital ichthyosis, characterized by erythema and blistering at birth followed by hyperkeratosis. EI is caused by pathogenic variants in the genes KRT1 and KRT10, encoding the proteins keratin 1 (KRT1) and keratin 10 (KRT10), respectively, and is primarily transmitted by autosomal-dominant inheritance, although recessive inheritance caused by nonsense variants in KRT10 is also described. The keratins form a network of intermediate filaments and are a structural component of the cytoskeleton, giving strength and resilience to the skin. We present three cases of mild EI caused by pathogenic KRT10 variations in the L12 linker domain. To our knowledge, this is the first time L12 linker domain pathogenic variants are identified in KRT10 for EI. The aim of this study was to identify gene variants for patients with EI in KRT1 or KRT10. To establish the pathogenicity of the found variations in KRT10, we evaluated all patients and available family members clinically. Genetic analyses were performed using Sanger sequencing. Vectors containing wild-type or mutated forms of KRT10 were transfected into HaCaT cells and analyzed by high-resolution confocal microscopy. Genetic analysis of KRT10 identified a heterozygous de novo variant c.910G>A p.(Val304Met) in family 1, a familial heterozygous variant c.911T>C p.(Val304Ala) in family 2, and a familial heterozygous variant c.917T>C p.(Met306Thr) in family 3. All identified missense variants were located in the L12 linker domain of KRT10. In vitro study of aggregate formation of the missense variants in KRT10 only showed a very mild and not quantifiable aggregate formation in the KRT10 network, compared with the wild-type sequence. We report three different novel missense variants in the L12 linker domain of KRT10 in patients with an atypical, milder form of EI resembling peeling skin syndrome.

Identifiants

pubmed: 39072839
doi: 10.1111/1346-8138.17395
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 The Author(s). The Journal of Dermatology published by John Wiley & Sons Australia, Ltd on behalf of Japanese Dermatological Association.

Références

Jacob JT, Coulombe PA, Kwan R, Omary MB. Types I and II keratin intermediate filaments. Cold Spring Harb Perspect Biol. 2018;10:a018275.
Mirza H, Kumar A, Craiglow BG, Zhou J, Saraceni C, Torbeck R, et al. Mutations affecting keratin 10 surface‐exposed residues highlight the structural basis of phenotypic variation in Epidermolytic ichthyosis. J Invest Dermatol. 2015;135:3041–3050.
Knobel M, O'Toole EA, Smith FJ. Keratins and skin disease. Cell Tissue Res. 2015;360:583–589.
Rice AS, Crane JS. Epidermolytic Hyperkeratosis. StatPearls. Treasure Island (FL): StatPearls Publishing; 2022.
Vodo D, Sarig O, Peled A, Samuelov L, Malchin N, Grafi‐Cohen M, et al. Recessive epidermolytic ichthyosis results from loss of keratin 10 expression, regardless of the mutation location. Clin Exp Dermatol. 2018;43:187–190.
March OP, Lettner T, Klausegger A, Ablinger M, Kocher T, Hainzl S, et al. Gene editing‐mediated disruption of Epidermolytic ichthyosis‐associated KRT10 alleles restores filament stability in keratinocytes. J Invest Dermatol. 2019;139:1699–710.e6.
Chamcheu JC, Siddiqui IA, Syed DN, Adhami VM, Liovic M, Mukhtar H. Keratin gene mutations in disorders of human skin and its appendages. Arch Biochem Biophys. 2011;508:123–137.
Haruna K, Suga Y, Mizuno Y, Hasegawa T, Kourou K, Matsuba S, et al. R156C mutation of keratin 10 causes mild form of epidermolytic hyperkeratosis. J Dermatol. 2007;34:545–548.
Virtanen M, Smith SK, Gedde‐Dahl T Jr, Vahlquist A, Bowden PE. Splice site and deletion mutations in keratin (KRT1 and KRT10) genes: unusual phenotypic alterations in Scandinavian patients with epidermolytic hyperkeratosis. J Invest Dermatol. 2003;121:1013–1020.
Ho M, Thompson B, Fisk JN, Nebert DW, Bruford EA, Vasiliou V, et al. Update of the keratin gene family: evolution, tissue‐specific expression patterns, and relevance to clinical disorders. Hum Genomics. 2022;16:1.
Rothnagel JA, Dominey AM, Dempsey LD, Longley MA, Greenhalgh DA, Gagne TA, et al. Mutations in the rod domains of keratins 1 and 10 in epidermolytic hyperkeratosis. Science. 1992;257:1128–1130.
Eldirany SA, Ho M, Hinbest AJ, Lomakin IB, Bunick CG. Human keratin 1/10‐1B tetramer structures reveal a knob‐pocket mechanism in intermediate filament assembly. EMBO J. 2019;38:e100741.
DiGiovanna JJ, Bale SJ. Clinical heterogeneity in epidermolytic hyperkeratosis. Arch Dermatol. 1994;130:1026–1035.
Bolling MC, Bladergroen RS, van Steensel MA, Willemsen M, Jonkman MF, van Geel M. A novel mutation in the L12 domain of keratin 1 is associated with mild epidermolytic ichthyosis. Br J Dermatol. 2010;162:875–879.
Nellen RG, Nagtzaam IF, Hoogeboom AJ, Bladergroen RS, Jonkman MF, Steijlen PM, et al. Phenotypic variation in epidermolytic ichthyosis: clinical and functional evaluation of the novel p.(Met339Lys) mutation in the L12 domain of KRT1. Exp Dermatol. 2015;24:883–885.
Kremer H, Lavrijsen AP, McLean WH, Lane EB, Melchers D, Ruiter DJ, et al. An atypical form of bullous congenital ichthyosiform erythroderma is caused by a mutation in the L12 linker region of keratin 1. J Invest Dermatol. 1998;111:1224–1226.
Bolling MC, Lemmink HH, Jansen GH, Jonkman MF. Mutations in KRT5 and KRT14 cause epidermolysis bullosa simplex in 75% of the patients. Br J Dermatol. 2011;164:637–644.
Consortium U. Uniprot. In, Vol. 2022. 2002–2022.
Syder AJ, Yu QC, Paller AS, Giudice G, Pearson R, Fuchs E. Genetic mutations in the K1 and K10 genes of patients with epidermolytic hyperkeratosis. Correlation between location and disease severity. J Clin Invest. 1994;93:1533–1542.
Richards S, Aziz N, Bale S, Bick D, das S, Gastier‐Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–424.
Rugg EL, Morley SM, Smith FJ, Boxer M, Tidman MJ, Navsaria H, et al. Missing links: weber‐Cockayne keratin mutations implicate the L12 linker domain in effective cytoskeleton function. Nat Genet. 1993;5:294–300.
Abu Sa'd J, Indelman M, Pfendner E, Falik‐Zaccai TC, Mizrachi‐Koren M, Shalev S, et al. Molecular epidemiology of hereditary epidermolysis bullosa in a middle eastern population. J Invest Dermatol. 2006;126:777–781.
Rugg EL, Horn HM, Smith FJ, Wilson NJ, Hill AJM, Magee GJ, et al. Epidermolysis bullosa simplex in Scotland caused by a spectrum of keratin mutations. J Invest Dermatol. 2007;127:574–580.
Wertheim‐Tysarowska K, Oldak M, Giza A, Kutkowska‐Kaźmierczak A, Sota J, Przybylska D, et al. Novel sporadic and recurrent mutations in KRT5 and KRT14 genes in polish epidermolysis bullosa simplex patients: further insights into epidemiology and genotype‐phenotype correlation. J Appl Genet. 2016;57:175–181.
Muller FB, Kuster W, Wodecki K, Almeida H Jr, Bruckner‐Tuderman L, Krieg T, et al. Novel and recurrent mutations in keratin KRT5 and KRT14 genes in epidermolysis bullosa simplex: implications for disease phenotype and keratin filament assembly. Hum Mutat. 2006;27:719–720.
Li H, Torma H. Retinoids reduce formation of keratin aggregates in heat‐stressed immortalized keratinocytes from an epidermolytic ichthyosis patient with a KRT10 mutation*. Acta Derm Venereol. 2013;93:44–49.
D'Alessandro M, Russell D, Morley SM, Davies AM, Lane EB. Keratin mutations of epidermolysis bullosa simplex alter the kinetics of stress response to osmotic shock. J Cell Sci. 2002;115:4341–4351.

Auteurs

J J A J van der Velden (JJAJ)

Department of Dermatology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
GROW-School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.

M W van Gisbergen (MW)

Department of Dermatology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
GROW-School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.

M A F Kamps (MAF)

Department of Dermatology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
GROW-School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.

R Janssen (R)

Department of Dermatology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
GROW-School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.

G F H Diercks (GFH)

Department of Dermatology, UMCG Center of Expertise for Blistering Diseases, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Department of Pathology, UMCG Center of Expertise for Blistering Diseases, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

P M Steijlen (PM)

Department of Dermatology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
GROW-School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.

M van Geel (M)

Department of Dermatology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
GROW-School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.
Department of Clinical Genetics, Maastricht University Medical Centre+, Maastricht, The Netherlands.

M C Bolling (MC)

Department of Dermatology, UMCG Center of Expertise for Blistering Diseases, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Classifications MeSH